IL-4 and Insulin Resistance for Treatment of Patients With Atopic Dermatitis
NCT05372003
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
7
Enrollment
OTHER
Sponsor class
Conditions
Atopic Dermatitis
Interventions
DRUG:
Dupilumab
OTHER:
Photo therapy
Sponsor
Mayo Clinic